Phibro Animal Health Net Income
| PAHC Stock | USD 51.27 0.25 0.49% |
As of the 13th of February 2026, Phibro Animal holds the Risk Adjusted Performance of 0.0755, semi deviation of 2.38, and Coefficient Of Variation of 1199.35. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Phibro Animal, as well as the relationship between them.
Phibro Animal Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.8952 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 37.5 M | 42.5 M | |
| Net Income | 55.5 M | 58.3 M | |
| Net Income From Continuing Ops | 43.4 M | 36.3 M | |
| Net Income Per Share | 1.07 | 1.13 | |
| Net Income Per E B T | 0.82 | 1.13 |
Phibro | Net Income | Build AI portfolio with Phibro Stock |
Analyzing Phibro Animal's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Phibro Animal's current valuation and future prospects.
Latest Phibro Animal's Net Income Growth Pattern
Below is the plot of the Net Income of Phibro Animal Health over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Phibro Animal Health financial statement analysis. It represents the amount of money remaining after all of Phibro Animal Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Phibro Animal's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phibro Animal's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 48.26 M | 10 Years Trend |
|
Net Income |
| Timeline |
Phibro Net Income Regression Statistics
| Arithmetic Mean | 41,189,846 | |
| Coefficient Of Variation | 61.19 | |
| Mean Deviation | 21,280,932 | |
| Median | 49,175,000 | |
| Standard Deviation | 25,205,320 | |
| Sample Variance | 635.3T | |
| Range | 85.8M | |
| R-Value | 0.31 | |
| Mean Square Error | 612.8T | |
| R-Squared | 0.1 | |
| Significance | 0.23 | |
| Slope | 1,543,854 | |
| Total Sum of Squares | 10164.9T |
Phibro Net Income History
Other Fundumenentals of Phibro Animal Health
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Phibro Animal Net Income component correlations
Phibro Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Phibro Animal is extremely important. It helps to project a fair market value of Phibro Stock properly, considering its historical fundamentals such as Net Income. Since Phibro Animal's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Phibro Animal's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Phibro Animal's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Pharmaceuticals sector continue expanding? Could Phibro diversify its offerings? Factors like these will boost the valuation of Phibro Animal. Anticipated expansion of Phibro directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Phibro Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 7.52 | Dividend Share 0.48 | Earnings Share 2.25 | Revenue Per Share | Quarterly Revenue Growth 0.209 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Phibro Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Phibro Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Phibro Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Phibro Animal 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Phibro Animal's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Phibro Animal.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Phibro Animal on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Phibro Animal Health or generate 0.0% return on investment in Phibro Animal over 90 days. Phibro Animal is related to or competes with Alvotech, Organon, Qilian International, Avadel Pharmaceuticals, Aurinia Pharmaceuticals, Tilray, and MannKind Corp. Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition pro... More
Phibro Animal Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Phibro Animal's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Phibro Animal Health upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.55 | |||
| Information Ratio | 0.0615 | |||
| Maximum Drawdown | 24.25 | |||
| Value At Risk | (4.49) | |||
| Potential Upside | 4.38 |
Phibro Animal Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Phibro Animal's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Phibro Animal's standard deviation. In reality, there are many statistical measures that can use Phibro Animal historical prices to predict the future Phibro Animal's volatility.| Risk Adjusted Performance | 0.0755 | |||
| Jensen Alpha | 0.2494 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0887 | |||
| Treynor Ratio | 0.4414 |
Phibro Animal February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0755 | |||
| Market Risk Adjusted Performance | 0.4514 | |||
| Mean Deviation | 2.21 | |||
| Semi Deviation | 2.38 | |||
| Downside Deviation | 2.55 | |||
| Coefficient Of Variation | 1199.35 | |||
| Standard Deviation | 3.68 | |||
| Variance | 13.56 | |||
| Information Ratio | 0.0615 | |||
| Jensen Alpha | 0.2494 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0887 | |||
| Treynor Ratio | 0.4414 | |||
| Maximum Drawdown | 24.25 | |||
| Value At Risk | (4.49) | |||
| Potential Upside | 4.38 | |||
| Downside Variance | 6.51 | |||
| Semi Variance | 5.67 | |||
| Expected Short fall | (2.72) | |||
| Skewness | 2.97 | |||
| Kurtosis | 17.98 |
Phibro Animal Health Backtested Returns
Phibro Animal appears to be very steady, given 3 months investment horizon. Phibro Animal Health maintains Sharpe Ratio (i.e., Efficiency) of 0.0752, which implies the firm had a 0.0752 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Phibro Animal Health, which you can use to evaluate the volatility of the company. Please evaluate Phibro Animal's Risk Adjusted Performance of 0.0755, coefficient of variation of 1199.35, and Semi Deviation of 2.38 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Phibro Animal holds a performance score of 5. The company holds a Beta of 0.67, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Phibro Animal's returns are expected to increase less than the market. However, during the bear market, the loss of holding Phibro Animal is expected to be smaller as well. Please check Phibro Animal's jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to make a quick decision on whether Phibro Animal's historical price patterns will revert.
Auto-correlation | -0.69 |
Very good reverse predictability
Phibro Animal Health has very good reverse predictability. Overlapping area represents the amount of predictability between Phibro Animal time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Phibro Animal Health price movement. The serial correlation of -0.69 indicates that around 69.0% of current Phibro Animal price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 20.92 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Phibro Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Phibro Animal Health reported net income of 48.26 M. This is 85.86% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 91.55% higher than that of the company.
Phibro Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phibro Animal's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phibro Animal could also be used in its relative valuation, which is a method of valuing Phibro Animal by comparing valuation metrics of similar companies.Phibro Animal is currently under evaluation in net income category among its peers.
Phibro Animal ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Phibro Animal's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Phibro Animal's managers, analysts, and investors.Environmental | Governance | Social |
Phibro Animal Institutional Holders
Institutional Holdings refers to the ownership stake in Phibro Animal that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Phibro Animal's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Phibro Animal's value.| Shares | Brandes Investment Partners & Co | 2025-06-30 | 375.4 K | Ranger Investment Management Lp | 2025-06-30 | 358 K | Millennium Management Llc | 2025-06-30 | 286.1 K | Arrowstreet Capital Limited Partnership | 2025-06-30 | 275.1 K | Bank Of New York Mellon Corp | 2025-06-30 | 268.9 K | Amvescap Plc. | 2025-06-30 | 263.1 K | Charles Schwab Investment Management Inc | 2025-06-30 | 259.9 K | Jacobs Levy Equity Management, Inc. | 2025-06-30 | 245 K | Crawford Investment Counsel, Inc | 2025-06-30 | 236.1 K | Blackrock Inc | 2025-06-30 | 3.5 M | Vanguard Group Inc | 2025-06-30 | 1.5 M |
Phibro Fundamentals
| Return On Equity | 0.32 | ||||
| Return On Asset | 0.0834 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 2.78 B | ||||
| Shares Outstanding | 20.62 M | ||||
| Shares Owned By Insiders | 0.65 % | ||||
| Shares Owned By Institutions | 96.79 % | ||||
| Number Of Shares Shorted | 1.05 M | ||||
| Price To Earning | 11.39 X | ||||
| Price To Book | 6.25 X | ||||
| Price To Sales | 1.42 X | ||||
| Revenue | 1.3 B | ||||
| Gross Profit | 473.02 M | ||||
| EBITDA | 146.85 M | ||||
| Net Income | 48.26 M | ||||
| Cash And Equivalents | 98.67 M | ||||
| Cash Per Share | 2.44 X | ||||
| Total Debt | 761.55 M | ||||
| Debt To Equity | 1.79 % | ||||
| Current Ratio | 2.97 X | ||||
| Book Value Per Share | 8.20 X | ||||
| Cash Flow From Operations | 80.12 M | ||||
| Short Ratio | 5.33 X | ||||
| Earnings Per Share | 2.25 X | ||||
| Price To Earnings To Growth | 1.66 X | ||||
| Target Price | 48.5 | ||||
| Number Of Employees | 2.48 K | ||||
| Beta | 0.8 | ||||
| Market Capitalization | 2.08 B | ||||
| Total Asset | 1.36 B | ||||
| Retained Earnings | 272.7 M | ||||
| Working Capital | 517.13 M | ||||
| Current Asset | 342.83 M | ||||
| Current Liabilities | 108.78 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.85 % | ||||
| Net Asset | 1.36 B | ||||
| Last Dividend Paid | 0.48 |
About Phibro Animal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phibro Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phibro Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phibro Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:Check out You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Will Pharmaceuticals sector continue expanding? Could Phibro diversify its offerings? Factors like these will boost the valuation of Phibro Animal. Anticipated expansion of Phibro directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Phibro Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 7.52 | Dividend Share 0.48 | Earnings Share 2.25 | Revenue Per Share | Quarterly Revenue Growth 0.209 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Phibro Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Phibro Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Phibro Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.